Article
Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.
Molecular and biochemical parasitology - 1 Mar 2001
Ferlan J T, Mookherjee S, Okezie I N, Fulgence L, Sibley C H
Abstract excerpt
Inhibitors of dihydrofolate reductase (DHFR) have been a mainstay of chemotherapy of falciparum malaria for >50 years. Unfortunately, point mutations in DHFR are the major cause of resistance to drugs of this class and mutations have rapidly diminished the clinical effectiveness of these drugs. We designed a simple yeast-based system to produce and analyze point mutations in the Plasmodium falciparum DHFR domain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
